Background Unusual presentations of multiple sclerosis (MS) at onset may post a diagnostic
dilemma to the treating neurologists. Spinal myoclonus is rare in MS and may lead to …

Multiple sclerosis (MS) is a chronic demyelinating disease affecting the CNS and is predominant
in the young population aged 20-40 years. The awareness of patients and caregivers …

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous
system. Multiple sclerosis has become one of the most prevalent neurological disorders …

Background Natalizumab, a highly specific α4-integrin antagonist, , has recently been
registered across the Middle East and North Africa region. It improves clinical and magnetic …

Importance Within 2 decades of onset, 80% of untreated patients with relapsing-remitting
multiple sclerosis (MS) convert to a phase of irreversible disability accrual termed secondary …

A number of studies have been conducted with the onset of secondary progressive multiple
sclerosis as an inclusion criterion or an outcome of interest. However, a standardized …

Background and Objectives People with multiple sclerosis (MS) are a vulnerable group for
severe coronavirus disease 2019 (COVID-19), particularly those taking immunosuppressive …

Background Pediatric-onset multiple sclerosis (POMS) prevalence and incidence rates are
increasing globally. No disease-modifying therapy are approved for MS pediatric population. …

Background Multiple Sclerosis is more common in women than men and females have more
relapses than men. In a large international cohort we have evaluated the effect of gender …

Objective To determine the rate of relapse occurrence during pregnancy and postpartum.
Methods In a cross-sectional study using the national multiple sclerosis (MS) registry, pregnant …